VIDEO: Biomarker testing 'important' for newly diagnosed metastatic colorectal cancer
Click Here to Manage Email Alerts
In this video, Christine M. Walko, PharmD, BCOP, FCCP, discussed the importance of biomarker testing and the challenges involved.
A discussion during the plenary session on the PARADIGM trial at ASCO Annual Meeting, led by Chiara Cremolini, MD, PhD, touched on how essential biomarker testing is for colorectal cancer patients, Walko, a personalized medicine specialist at DeBartolo Family Personalized Medicine Institute in Tampa, Florida, said.
"For a newly diagnosed patient with metastatic colorectal cancer, we need to get biomarker testing. That is really important before we start treatment," Walko said.
She said challenges include collecting enough tissue from the initial pathology diagnosis.
"Not everyone has access to those tests in the same way, but in order to benefit from the findings that we saw at this meeting, it is going to be really important that we make sure that that technology is where patients are being treated so that patients can be treated with the best therapy," Walko said.
Collapse
Read more about
Click Here to Manage Email Alerts